Geneos Wealth Management Inc.
Q1 2019 13F-HR Holdings
Net value change ($000)
+163,781
(12.1%)
New positions
116
Sold out positions
94
Turnover %
1.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2018
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GSY | 10,917 | 1186.6% |
| IVV | 8,925 | 18.1% |
| USMV | 7,733 | 53.0% |
| TIP | 6,730 | 905.8% |
| STIP | 6,626 | 8834.7% |
| ROM | 5,836 | NEW |
| URE | 5,807 | NEW |
| PEP | 5,699 | 130.1% |
| USDGBX | 5,424 | NEW |
| RXL | 5,132 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| IWB | -14,685 | -99.5% |
| SPY | -5,346 | -13.0% |
| QQQ | -4,556 | -44.4% |
| WHR | -4,390 | -98.5% |
| Hanesbrands Inc. | -4,244 | -93.2% |
| KMB | -4,100 | -62.2% |
| VLUE | -3,774 | -98.0% |
| VUG | -3,690 | -37.6% |
| Accelerate Diagnostics, Inc | -3,209 | -99.9% |
| KXI | -2,989 | -94.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|